- Home
- LODE vs ATRA Comparison
LODE vs ATRA Comparison
Compare LODE & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LODE
- ATRA
- Stock Information
- Founded
- LODE 2008
- ATRA 2012
- Country
- LODE United States
- ATRA United States
- Employees
- LODE N/A
- ATRA N/A
- Industry
- LODE Major Chemicals
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LODE Industrials
- ATRA Health Care
- Exchange
- LODE Nasdaq
- ATRA Nasdaq
- Market Cap
- LODE 119.2M
- ATRA 97.0M
- IPO Year
- LODE N/A
- ATRA 2014
- Fundamental
- Price
- LODE $3.77
- ATRA $16.22
- Analyst Decision
- LODE Hold
- ATRA Strong Buy
- Analyst Count
- LODE 1
- ATRA 3
- Target Price
- LODE $4.00
- ATRA $21.00
- AVG Volume (30 Days)
- LODE 1.4M
- ATRA 56.5K
- Earning Date
- LODE 11-14-2025
- ATRA 11-11-2025
- Dividend Yield
- LODE N/A
- ATRA N/A
- EPS Growth
- LODE N/A
- ATRA N/A
- EPS
- LODE N/A
- ATRA 0.56
- Revenue
- LODE $3,280,749.00
- ATRA $188,667,000.00
- Revenue This Year
- LODE $7.65
- ATRA N/A
- Revenue Next Year
- LODE $1,093.72
- ATRA N/A
- P/E Ratio
- LODE N/A
- ATRA $29.22
- Revenue Growth
- LODE 58.55
- ATRA 202.41
- 52 Week Low
- LODE $1.67
- ATRA $5.01
- 52 Week High
- LODE $10.10
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- LODE 63.37
- ATRA 77.09
- Support Level
- LODE $3.48
- ATRA $13.92
- Resistance Level
- LODE $3.84
- ATRA $14.84
- Average True Range (ATR)
- LODE 0.25
- ATRA 0.98
- MACD
- LODE 0.01
- ATRA 0.22
- Stochastic Oscillator
- LODE 61.71
- ATRA 87.52
About LODE Comstock Inc.
Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).